Primary lung cancer is the second most common cancer in both men and women. More than 210,000 cases of lung cancer are diagnosed every year in the United States. It is the leading cause of cancer deaths and outnumbers the deaths from some of the next most common cancers added together. In general terms, lung cancer can be divided into two major groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLCs account for approximately 85 percent of the lung cancer cases and SCLCs account for approximately 15 percent of the lung cancer cases.
The nationally and internationally renowned thoracic surgeons at Yale work as part of a multidisciplinary team with Yale Thoracic Oncology surgeons and specialists, who are also nationally and internationally renowned for their specialized lung cancer care. Our practice encompasses all aspects of your total lung health including diagnosis, treatment, and follow-up care. As faculty of the Yale School of Medicine Department of Surgery, our surgeons are continually redefining standards of care through their comprehensive skill, innovative procedures, ongoing research, and the application of evidence-based medicine.